Global Hyaluronic Acid Market Size, Share, Opportunities, And Trends By Application (Tissue Engineering, Osteoarthritis Treatment, Dermal Filler, Others) And By Geography - Forecasts From 2025 To 2030

  • Published : Jun 2025
  • Report Code : KSI061613831
  • Pages : 145
excel pdf power-point

Hyaluronic Acid Market Size:

The hyaluronic acid market is expected to surge from USD 10.929 billion in 2025 to USD 15.336 billion in 2030, with a 7.01% CAGR.

Hyaluronic acid (HA) is naturally available in the human body. In eyes and joints, HA is found in the highest concentrations. The substance has the ability to keep skin plump and moist. Hence, it is utilized by many cosmetic surgeons in the form of injectables to reduce aging on the skin.

The growing global geriatric population is projected to surge the market growth during the forecast period. The presence of companies offering advanced hyaluronic acid solutions for customers worldwide is further augmenting the market growth during the forecast period. Hyaluronic acid can be found in the form of serums, sheet masks, and dermal fillers. Popular brand names for hyaluronic acid fillers include Juvederm, Elevess, Puragen, and Captique among others. The growing adoption of minimally invasive procedures for cosmetic procedures is further propelling the market growth during the forecast period.

Hyaluronic Acid Market Drivers:

  • The soaring dermal filler procedures worldwide are augmenting the growth of the global hyaluronic acid market during the forecast period.

The market is projected to soar with the growing number of dermal filler procedures in the world. There is an increasing interest among consumers to look young and thus this has surged the demand for cosmetic procedures that include hyaluronic acid dermal filler consumption, further propelling the market demand during the forecast period. The dermal fillers help in filling wrinkles and are utilized to add volume to the soft tissues, thus giving them a full and voluptuous look. These gel injections are inserted in different areas of the body including lips, cheeks, jawline, and lips.

Other factors fueling the demand for dermal filler procedures include the immediate effects observed after application. This reduces the signs of aging and provides consumers the near-instant satisfaction. The currently growing selfie trend and uploading it on the social media platform have raised the growth prospects of these procedures. Consumers seek measures that make them look beautiful while posting pictures on social media platforms. The increasing aging worldwide is further augmenting the market growth demanding dermal filler procedures during the forecast period. The total population 65 years of age and above is predicted to surge from 55,11,19,375 in 2012 to 69,79,67,728 in 2019 (source: The World Bank).

The increasing interest of men to look their best, apart from women is further adding to surging the demand for dermal fillers, propagating the market growth during the forecast period. These groups of people are quite comfortable with the available aesthetic procedures offering innovative options to enhance their looks. Additionally, the convenient methods to administer hyaluronic acid into the human skin are further propelling the market demand owing to the consumer-friendliness of the cosmetic procedures that are minimally invasive and are least painful offering huge gains.

With the increasing disposable income worldwide, especially, in the developing regions of the world, the demand for dermal fillers is continuing to grow. This is mainly attributed to increasing consumer spending ability, further offering them options to look above their basic expenditures and hence, are willing to spend on sophisticated cosmetic procedures. According to the National Bureau of Statistics Data, the per capita consumer spending in China rose to 21,559 yuan in 2019, an increase of 5.5% y-o-y.

There is a wide availability of dermal fillers in the market, these include temporary, permanent, and semi-permanent fillers. Most of the non-permanent fillers are safer to use and are FDA-approved, these include hyaluronic-based fillers as well. 

  • The presence of companies offering innovative hyaluronic acid-based products is fueling the market growth during the forecast period.

Galderma, focused on offering science-based solutions for skin health through its Restylane® brand offers a diverse range of hyaluronic-acid-based commodities segregated into two product groups namely, Restylane fillers and Restylane Skinboosters.

The fillers category is a combination of two unique technologies involving OBT and NASHTA™. These have further established safety profiles for more than two decades of experience and Offers high patient satisfaction with around 40 million treatments in the world. The product portfolio includes Restylane Fynesse™, Restylane Refyne™, Restylane, and Restylane Volyme™ for the restoration of youthful appearance that includes filling fine lines and wrinkles and replacing the lost fullness and volume due to aging. Restylane Defyne™, Restylane Lyft™, and Restylane Kysse™ are used for enhancing the appearance for the creation of harmony and balance and for the enhancement of the shape, contour, and definition.

The Skinboosters category offers solutions for skin rejuvenation for delivering hydration and skin imperfection improvement, thus leading to radiant and healthy skin.

Humedix Co., Ltd. offers hyaluronic acid as the active pharmaceutical ingredient for applications in eye drops, ophthalmology injections, beauty fillers, and osteoarthritis drugs.

Kewpie Corporation offers hyaluronic acid for cosmetic applications. Products include HAbooster™, Hyalo-Oligo®, Hyaloveil®-P, and Hyalorepair®. The HAbooster is a collagen cycle accelerator hyaluronic acid, a novel product having a super low molecular weight of around 2000. Further promoting the collagen cycle and increasing skin moisture. The low molecular hyaluronic acid, Hyalo-oligo has an average molecular weight lesser than 10,000. It soaks into the skin's hard layer and imparts moisture from inside the skin. Hyaloveli-P is a hyaluronic acid containing adsorptive properties that stay in hair and on the skin even when rinsed with water. Hence this contributes to sustained moisture even after the washing-off of the hyaluronic acid. Hyalorepair is a lamellar structure reviving hyaluronic acid that contains the properties of hydrophilic and hydrophobic groups. This further contributed to enhancing and reviving the skin’s barrier functionality, further resulting in smoother skin.

Hyaluronic Acid Market Geographical Outlook:

On the basis of geography, the market is segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific region. North America is projected to hold a significant market share owing to the early adoption of technologies and innovation. Additionally, the substantial aging population along with increasing susceptibility to age-associated diseases like osteoarthritis is further contributing to fueling the market demand during the forecast period. The Asia Pacific region is estimated to account for a substantial market share owing to the increasing interest in the adoption of anti-aging products.

Segmentation:

  • By Application
    • Tissue Engineering
    • Osteoarthritis Treatment
    • Dermal Filler
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Others
    • Middle East and Africa
      • UAE
      • Israel
      • Saudi Arabia
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Others
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
 
2. Research Methodology
2.1. Research Data
2.2. Assumptions
 
3. Executive Summary
3.1. Research Highlights
 
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
 
5. Global Hyaluronic Acid Market Analysis, by Application
5.1. Introduction
5.2. Tissue Engineering
5.3. Osteoarthritis Treatment 
5.4. Dermal Filler
5.5. Others
 
6. Global Hyaluronic Acid Market Analysis, by Geography
6.1. Introduction
6.2. North America
6.2.1. North America Hyaluronic Acid Market, By Application, 2019 to 2025
6.2.2. By Country
6.2.2.1. United States
6.2.2.2. Canada
6.2.2.3. Mexico
6.3. South America
6.3.1. South America Hyaluronic Acid Market, By Application, 2019 to 2025
6.3.2. By Country
6.3.2.1. Brazil
6.3.2.2. Argentina
6.3.2.3. Others
6.4. Europe
6.4.1. Europe Hyaluronic Acid Market, By Application, 2019 to 2025
6.4.2. By Country
6.4.2.1. UK
6.4.2.2. Germany
6.4.2.3. France
6.4.2.4. Others
6.5. Middle East and Africa
6.5.1. Middle East and Africa Hyaluronic Acid Market, By Application, 2019 to 2025
6.5.2. By Country
6.5.2.1. United Arab Emirates
6.5.2.2. Israel
6.5.2.3. Saudi Arabia
6.5.2.4. Others
6.6. Asia Pacific
6.6.1. Asia Pacific Hyaluronic Acid Market, By Application, 2019 to 2025
6.6.2. By Country
6.6.2.1. Japan
6.6.2.2. China
6.6.2.3. India
6.6.2.4. Australia
6.6.2.5. Others
 
7. Competitive Environment and Analysis
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
 
8. Company Profiles 
8.1. Allergan (AbbVie Inc.)
8.2. Sanofi
8.3. Seikagaku Corporation 
8.4. Contipro a.s.
8.5. BioScience GmbH 
8.6. Kewpie Corporation 
8.7. Bohus BioTech AB
8.8. Humedix.Co.Ltd
8.9. Anika Therapeutics, Inc.  
8.10. Laboratoires Vivacy, S.A.S.
8.11. Cosmedica Skincare
8.12. Wellona Pharma
8.13. Plamed Green Science Group
8.14. Revitajal (Beauty Aesthetic Finland Oy)
8.15. Altergon Italy Srl

Allergan (AbbVie Inc.)

Sanofi

Seikagaku Corporation

Contipro a.s.

BioScience GmbH

Kewpie Corporation

Bohus BioTech AB

Humedix.Co.Ltd

Anika Therapeutics, Inc. 

Laboratoires Vivacy, S.A.S.

Cosmedica Skincare

Wellona Pharma

Plamed Green Science Group

Revitajal (Beauty Aesthetic Finland Oy)

Altergon Italy Srl